This inventor holds 3 USPTO granted patents. Top assignees: The Hong Kong University of Science and Technology, Bayer Aktiengesellschaft. Active years: 2006-2008.
Company Filing History:
2 out of 650 
1 out of 12,266 
Years Active: 2006-2008
Title: The Innovations of Man-Ki Cheung
Introduction
Man-Ki Cheung is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiparasitic compounds. With a total of 3 patents to his name, Cheung's work has the potential to impact the treatment of various parasitic diseases.
Latest Patents
One of Cheung's latest patents focuses on antiparasitic artemisinin derivatives, specifically endoperoxides. This invention pertains to the use of certain C-10 substituted derivatives of artemisinin in the treatment and/or prophylaxis of diseases caused by parasitic infections. The patent details novel C-10 substituted derivatives of artemisinin, processes for their preparation, and pharmaceutical compositions containing these derivatives. The compounds are particularly effective in treating malaria, neosporosis, and coccidiosis.
Career Highlights
Throughout his career, Man-Ki Cheung has worked with prestigious institutions, including The Hong Kong University of Science and Technology and Bayer Aktiengesellschaft. His research and innovations have contributed to advancements in the pharmaceutical industry, particularly in combating parasitic diseases.
Collaborations
Cheung has collaborated with notable individuals in his field, including Gisela Greif and Gabriele Schmuck. These collaborations have likely enriched his research and contributed to the success of his inventions.
Conclusion
Man-Ki Cheung's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to addressing significant health challenges. His work in developing effective treatments for parasitic diseases highlights the importance of innovation in the medical field.